These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28000348)

  • 1. No association between Borrelia burgdorferi antibodies and amyotrophic lateral sclerosis in a case-control study.
    Visser AE; Verduyn Lunel FM; Veldink JH; van den Berg LH
    Eur J Neurol; 2017 Jan; 24(1):227-230. PubMed ID: 28000348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of IgG antibody seropositivity to Borrelia burgdorferi in patients with Parry-Romberg syndrome and linear morphea en coup de sabre in Mexico.
    Gutiérrez-Gómez C; Godínez-Hana AL; García-Hernández M; Suárez-Roa Mde L; Toussaint-Caire S; Vega-Memije E; Gutiérrez-Mendoza D; Pérez-Dosal M; Medina-De la Garza CE
    Int J Dermatol; 2014 Aug; 53(8):947-51. PubMed ID: 24527729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.
    Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW
    Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of Borrelia burgdorferi and tick-borne encephalitis virus in a rural area of Samsun, Turkey].
    Aslan Başbulut E; Gözalan A; Sönmez C; Cöplü N; Körhasan B; Esen B; Akın L; Ertek M
    Mikrobiyol Bul; 2012 Apr; 46(2):247-56. PubMed ID: 22639313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease.
    Halperin JJ; Kaplan GP; Brazinsky S; Tsai TF; Cheng T; Ironside A; Wu P; Delfiner J; Golightly M; Brown RH
    Arch Neurol; 1990 May; 47(5):586-94. PubMed ID: 2334308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre.
    Bernard A; Kodjikian L; Abukhashabh A; Roure-Sobas C; Boibieux A; Denis P; Broussolle C; Seve P
    Br J Ophthalmol; 2018 Mar; 102(3):369-372. PubMed ID: 28659389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher prevalence of antibodies to Borrelia burgdorferi in psychiatric patients than in healthy subjects.
    Hájek T; Pasková B; Janovská D; Bahbouh R; Hájek P; Libiger J; Höschl C
    Am J Psychiatry; 2002 Feb; 159(2):297-301. PubMed ID: 11823274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Value for Routine Serologic Screening for Borrelia burgdorferi in Patients With Uveitis in the Netherlands.
    Kazi H; de Groot-Mijnes JDF; Ten Dam-van Loon NH; Ossewaarde-van Norel J; Oosterheert JJ; de Boer JH
    Am J Ophthalmol; 2016 Jun; 166():189-193. PubMed ID: 27080573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of antibodies to Borrelia burgdorferi sensu lato in healthy adults from western Norway: risk factors and methodological aspects.
    Hjetland R; Nilsen RM; Grude N; Ulvestad E
    APMIS; 2014 Nov; 122(11):1114-24. PubMed ID: 24730472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent lesson from a clinical and seroepidemiological survey: low positive predictive value of Borrelia burgdorferi antibody testing in a high risk population.
    Lakos A; Igari Z; Solymosi N
    Adv Med Sci; 2012; 57(2):356-63. PubMed ID: 23314562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy.
    Tomao P; Ciceroni L; D'Ovidio MC; De Rosa M; Vonesch N; Iavicoli S; Signorini S; Ciarrocchi S; Ciufolini MG; Fiorentini C; Papaleo B
    Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):457-63. PubMed ID: 15948001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Borrelia burgdorferi in patients with Behçet's disease.
    Onen F; Tuncer D; Akar S; Birlik M; Akkoc N
    Rheumatol Int; 2003 Nov; 23(6):289-93. PubMed ID: 12682785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinuclear antibodies are not increased in the early phase of Borrelia infection.
    Spiewak R; Stojek NM; Chmielewska-Badora J
    Ann Agric Environ Med; 2004; 11(1):145-8. PubMed ID: 15236512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A biochip-based combined immunoassay for detection of serological status of Borrelia burgdorferi in Lyme borreliosis.
    Huang NL; Ye L; Lv H; Du YX; Schneider M; Fan LB; Du WD
    Clin Chim Acta; 2017 Sep; 472():13-19. PubMed ID: 28676442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cardiac conduction disorders, and pacemaker implantations among individuals tested for serum Borrelia burgdorferi antibodies, a nationwide, matched, population-based cohort study.
    Tetens MM; Omland LH; Dessau RB; Ellermann-Eriksen S; Andersen NS; Jørgensen CS; Østergaard C; Bodilsen J; Søgaard KK; Bangsborg J; Nielsen AC; Møller JK; Chen M; Svendsen JH; Obel N; Lebech AM
    Clin Microbiol Infect; 2024 May; 30(5):621-629. PubMed ID: 38316360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about their aetiology.
    Markowicz M; Kivaranovic D; Stanek G
    Clin Microbiol Infect; 2015 Dec; 21(12):1098-103. PubMed ID: 26321669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
    Christova I
    Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical differences in seroprevalence of Borrelia burgdorferi antibodies in Norway, 2011-2013.
    Vestrheim DF; White RA; Aaberge IS; Aase A
    Ticks Tick Borne Dis; 2016 Jul; 7(5):698-702. PubMed ID: 26961275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to Borrelia burgdorferi in erythema migrans patients.
    Trnovcova M; Bazovska S; Svecova D
    Bratisl Lek Listy; 2007; 108(9):399-402. PubMed ID: 18225477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.